Importance of clonal hematopoiesis in heart failure

Nicholas W Chavkin1, Kyung-Duk Min1, Kenneth Walsh1

  • 1Berne Cardiovascular Research Center USA; Department of Cardiology USA; Hematovascular Biology Center, University of Virginia, School of Medicine, Charlottesville, VA, 22908 USA.

Insights

Clonal hematopoiesis, driven by aging-related mutations, promotes inflammation and heart failure progression. This review explores the link between these conditions and their impact on cardiac health.

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Geriatrics

Background:

  • Heart failure is common in older adults.
  • Inflammation exacerbates heart failure by disrupting tissue repair and promoting pathological remodeling.
  • Aging alters immune cells via clonal hematopoiesis, characterized by mutations in driver genes leading to expanded, pro-inflammatory hematopoietic cells.

Purpose of the Study:

  • To review evidence linking clonal hematopoiesis to heart failure progression.
  • To elucidate the mechanistic connections between clonal hematopoiesis and cardiac inflammation.
  • To suggest future research avenues in this field.

Main Methods:

  • Review of current clinical and experimental studies.
  • Analysis of mechanistic pathways.
  • Synthesis of existing evidence.

Main Results:

  • Clonal hematopoiesis is frequently observed in heart failure patients.
  • Clonal hematopoiesis is associated with poorer prognosis in heart failure.
  • Mutant hematopoietic clones exhibit overactive inflammatory properties.

Conclusions:

  • Clonal hematopoiesis is a significant factor in heart failure progression.
  • Understanding the inflammatory mechanisms driven by clonal hematopoiesis is crucial for managing heart failure in the elderly.
  • Further research is needed to explore therapeutic strategies targeting clonal hematopoiesis in heart failure.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.1K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
154
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
7.6K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
189
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.5K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.6K